19
Participants
Start Date
November 15, 2022
Primary Completion Date
February 12, 2024
Study Completion Date
February 12, 2024
SEP-363856
SEP-363856 will be supplied as over-encapsulated tablets. Multiple tablets may be required to achieve a single dose.
Prior antipsychotic (risperidone, olanzapine, quetiapine or aripiprazole)
PA will be prepared by the pharmacy staff according to the patient's prescribed treatment and will be orally administered. Multiple tablets or capsules may be required to achieve a single dose.
Midwest Clinical Research Center, Dayton
Woodland International Research Group, Little Rock
Shari DeSilva, Rogers
Endeavor Clinical Trials, San Antonio
Otsuka Pharmaceutical Development & Commercialization, Inc.
INDUSTRY